OverviewSuggest Edit

Serotiny is a company that is engaged in the discovery of proteins for cell therapies. It focuses on such proteins as CARs (chimeric antigen receptors) for the treatment of cancers and genetic disorders.


Latest Updates

Employees (est.) (Jun 2022)12(-7%)
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Serotiny Financials and Metrics

Summary Metrics

Founding Date


Serotiny total Funding

$3 m

Serotiny latest funding size

$3 m

Time since last funding

4 years ago

Serotiny investors

Serotiny's latest funding round in July 2018 was reported to be $3 m. In total, Serotiny has raised $3 m
Show all financial metrics

Serotiny Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Serotiny Online and Social Media Presence

Embed Graph

Serotiny Frequently Asked Questions

  • When was Serotiny founded?

    Serotiny was founded in 2014.

  • How many employees does Serotiny have?

    Serotiny has 12 employees.

  • Who are Serotiny competitors?

    Competitors of Serotiny include Redbiotec, Kelonia Therapeutics and Instil Bio.